- ICH GCP
- EU-register voor klinische proeven
Laatste proeven
EudraCT Number: 2004-000053-34 | Sponsor Protocol Number: 0473081 | Start Date: 2004-07-28 | |||||||||||
Sponsor Name: Orion Corporation, Orion Pharma, Orionintie, | |||||||||||||
Full Title: Comparison of continuous combined estrogen-progestin regimen in alleviation of estrogen deficiency symptoms of postmenopausal women. A randomized, double-blind, fixed dose, multicentre phase IIIb ... | |||||||||||||
Medical condition: Postmenopausal estrogen replacement regimen is the therapy of choice for the alleviation of climacteric symptoms. During the past few years, continuous-combined hormone replacement therapy (HRT) ... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: CZ (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-000047-18 | Sponsor Protocol Number: C-1808 | Start Date: 2004-07-27 | ||||||
Sponsor Name: Biogen Idec Ltd. | ||||||||
Full Title: An open-label, multicenter extension study to evaluate the safety and tolerability of natalizumab in subjects with multiple sclerosis who have completed studies C-1801, C-1802, or C-1803. | ||||||||
Medical condition: Male and female subjects with multiple sclerosis who have completed natalizumab studies C-1801, C-1802, or C-1803 | ||||||||
|
||||||||
Population Age: Adults | Gender: Male, Female | |||||||
Trial protocol: SE (Completed) | ||||||||
Trial results: View results |
EudraCT Number: 2004-001125-20 | Sponsor Protocol Number: FIRM-ACT | Start Date: 2004-07-26 | |||||||||||
Sponsor Name: AZIENDA OSPEDALIERA S. LUIGI GONZAGA | |||||||||||||
Full Title: First International Randomized trial in Metastatic Adrenocortical Cancer Treatment FIRM-ACT Etoposide, Doxorubicin, Cisplatin and Mitotane vs. Streptozotocin and Mitotane | |||||||||||||
Medical condition: Chemotherapy in patients with locally advanced or metastatic adrenocortical cancer in adults and children | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-000562-13 | Sponsor Protocol Number: 3151A1-309-EU | Start Date: 2004-07-26 | ||||||
Sponsor Name: Wyeth Research Division of Wyeth Pharmaceuticals Inc. Clinical Research and Development | ||||||||
Full Title: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, FLEXIBLE-DOSE STUDY OF DVS-233 SR AND VENLAFAXINE ER IN ADULT OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER | ||||||||
Medical condition: Major depressive disorder | ||||||||
|
||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||
Trial protocol: LV (Completed) LT (Completed) | ||||||||
Trial results: View results |
EudraCT Number: 2004-001201-10 | Sponsor Protocol Number: FEN-PPA-401 | Start Date: 2004-07-26 | |||||||||||
Sponsor Name: JANSSEN-CILAG | |||||||||||||
Full Title: Comparison of transdermal fentanyl PCA and IV morphine PCA in the management of post-operative pain control. | |||||||||||||
Medical condition: Treatment of moderate to severe post-operative pain in subjects who have undergone an elective major abdominal or orthopaedic surgical procedure. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-000795-14 | Sponsor Protocol Number: 0089 | Start Date: 2004-07-26 | ||||||
Sponsor Name: AstraZeneca | ||||||||
Full Title: A Multicentre, Randomised, Double-blind, Placebo-controlled, Study on the Use of Prophylactic Meropenem Therapy in Subjects with Severe Acute Necrotizing Pancreatitis | ||||||||
Medical condition: severe acute necrotisng pancreatitis | ||||||||
|
||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||
Trial protocol: LV (Completed) LT (Completed) | ||||||||
Trial results: View results |
EudraCT Number: 2004-001041-15 | Sponsor Protocol Number: N3D/FOR-OCA-06 | Start Date: 2004-07-26 | ||||||
Sponsor Name: Neuro3d | ||||||||
Full Title: MULTICENTRE, DOUBLE-BLIND, RISING DOSE PARALLEL GROUP STUDY OF THE EFFICACY AND TOLERABILITY OF OCAPERIDONE VERSUS OLANZAPINE IN SCHIZOPHRENIC PATIENTS | ||||||||
Medical condition: The populations of the study will be: -schizophrenic patients according to DSM IV-TR diagnosis -have to present the first symptoms of the schizophrenia for at least one year -have to present an exa... | ||||||||
|
||||||||
Population Age: Adults | Gender: Male, Female | |||||||
Trial protocol: LV (Completed) | ||||||||
Trial results: (No results available) |
EudraCT Number: 2004-002280-24 | Sponsor Protocol Number: NILG-HES 1-03 | Start Date: 2004-07-26 | |||||||||||
Sponsor Name: AZIENDA OSPEDALIERA "OSPEDALI RIUNITI DI BERGAMO" (A.O. DI RILIEVO NAZIONALE) | |||||||||||||
Full Title: THERAPEUTIC AND BIOLOGICAL EFFECTS OF IMATINIB MESYLATE (STI571) IN PRIMARY HYPERESINOPHILIC SYNDROME (HES), CHRONIC EOSINOPHILIC LEUKEMIA (CEL) AND CHRONIC IDIOPHATIC HYPEREOSINOPHILIA (CIH): A ST... | |||||||||||||
Medical condition: HYPEREOSINOPHILIC SYNDROME (HES, CEL, CIH) | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-000337-12 | Sponsor Protocol Number: 24810 | Start Date: 2004-07-23 | |||||||||||
Sponsor Name: Serono International SA | |||||||||||||
Full Title: A multicentre, single arm, open-label, phase IV study to evaluate the immunogenicity and safety of subcutaneously administered r-hIFN beta-1a (Rebif) using clone 484-39 in the treatment of subjects... | |||||||||||||
Medical condition: MS with 2 or more relapses within the last 2 years | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-000362-12 | Sponsor Protocol Number: K-832-2.01EU | Start Date: 2004-07-23 | |||||||||||
Sponsor Name: Kowa Research Europe Ltd | |||||||||||||
Full Title: A Double-Blind, Randomised, Dose-Ranging Study to Compare K-832 with Placebo in the treatment of Patients with Active Rheumatoid Arthritis | |||||||||||||
Medical condition: Rheumatoid Arthritis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) | |||||||||||||
Trial results: View results |